Epigenomics AG Pursuing Development of Tamoxifen Response Test BERLIN and SEATTLE, Jan. 30, 2006 (PRIMEZONE) -- Epigenomics AG (Other OTC:EPGNF) (Frankfurt:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that Roche...

MorphoSys and Chemicon International Enter into Worldwide Licensing Agreement for Research Antibodies MARTINSRIED, Germany, Jan. 10, 2006 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) and Chemicon International, Inc., a subsidiary of Serologicals Corporation (Nasdaq:SERO)...